{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:40Z","timestamp":1787010100130,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T00:00:00Z","timestamp":1515024000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/ije\/dyx270","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T12:27:23Z","timestamp":1513168043000},"page":"550-560","source":"Crossref","is-referenced-by-count":67,"title":["Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3141-7496","authenticated-orcid":false,"given":"Aaron G","family":"Lim","sequence":"first","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Pakistan Health Research Council, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Pakistan Health Research Council, Islamabad, Pakistan"},{"name":"TEPHINET, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[{"name":"Aga Khan University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte F","family":"Davies","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Trickey","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Glass","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quaid","family":"Saeed","sequence":"additional","affiliation":[{"name":"National AIDS Control Programme, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Fraser","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine G","family":"Walker","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christinah","family":"Mukandavire","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K","family":"Martin","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"Division of Global Public Health, Department of Medicine, University of California San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret T","family":"May","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Averhoff","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"key\n\t\t\t\t20180626060801_dyx270-B1","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61(Suppl 1)","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B2","volume-title":"Global Hepatitis Report, 2017","author":"World Health Organization","year":"2017"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2015.01.004","article-title":"A path to eradication of hepatitis C in low- and middle-income countries","volume":"119","author":"Graham","year":"2015","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B4","volume-title":"Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B5","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2893.2009.01230.x","article-title":"Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan","volume":"17","author":"Janjua","year":"2010","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B7","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.26719\/2010.16.Supp.15","article-title":"Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures","volume":"16(Suppl)","author":"Qureshi","year":"2010","journal-title":"East Mediterr Health J"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B8","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.3748\/wjg.15.5647","article-title":"Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors","volume":"15","author":"Waheed","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"40","key":"key\n\t\t\t\t20180626060801_dyx270-B9","first-page":"1385","article-title":"Establishment of a viral hepatitis surveillance system, Pakistan, 2009-2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s13187-010-0086-x","article-title":"Educational intervention among barbers about liver cancer-inducing viruses: a pilot study from a developing country","volume":"25","author":"Krishanani","year":"2010","journal-title":"J Cancer Educ"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2468-1253(17)30045-6","article-title":"Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study","volume":"2","author":"European Union HCV Collaborators","year":"2017","journal-title":"Lancet Gastroentero Hepatol"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jvh.12351","article-title":"The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm. Vol. 2","volume":"22(Suppl 1)","author":"Hatzakis","year":"2015","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm","volume":"21(Suppl 1)","author":"Razavi","year":"2014","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jvh.12476","article-title":"The present and future disease burden of hepatitis C virus infections with today's treatment paradigm. Vol. 3","volume":"22(Suppl 4)","author":"Sibley","year":"2015","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jvh.12671","article-title":"Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention","volume":"24","author":"Ayoub","year":"2016","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B17","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/S2214-109X(14)70188-3","article-title":"Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study","volume":"2","author":"Breban","year":"2014","journal-title":"Lancet Global Health"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B18","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61(Suppl 1)","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158(Pt 1)","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B20","author":"United Nations"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B21","author":"United Nations Office on Drugs and Crime"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B24","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4269\/ajtmh.17-0019","article-title":"Importance and contribution of community, social, and healthcare risk factors for hepatitis C Infection in Pakistan","volume":"97","author":"Trickey","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B26","volume-title":"Health Indicators of Pakistan","author":"Nishtar","year":"2007"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B27","volume-title":"National Health Survey of Pakistan: Health Profile of the People of Pakistan, 1990-94","author":"Pakistan Medical Research Council","year":"1998"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B28","volume-title":"Malaria Indicator Survey in 38 High Risk Districts of Pakistan 2013-2014","author":"Pakistan Medical Research Council, Directorate of Malaria Control, Save The Children","year":"2015"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B29","volume-title":"Health System Profile 2007 \u2013 Pakistan","author":"Regional Health Systems Observatory, World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B30","first-page":"220","article-title":"Treatment of hepatitis B and C through national programme \u2013 an audit","volume":"63","author":"Qureshi","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B31","first-page":"68","article-title":"Hepatitis C, a mega menace: a Pakistani perspective","volume":"2","author":"Umar","year":"2012","journal-title":"J Pioneer Med Sci"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B32","volume-title":"Global Report on Access to Hepatitis C Treatment","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B33","volume-title":"A National Strategy for the Elimination of Hepatitis B and C","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B34","volume-title":"Combating Hepatitis B and C to Reach Elimination by 2030: Advocacy Brief.","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.15585\/mmwr.mm6541a2","article-title":"National progress toward hepatitis C elimination \u2013 Georgia, 2015-2016","volume":"65","author":"Gvinjilia","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B36","first-page":"CD012021","article-title":"Effectiveness of needle\/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs","volume":"2016","author":"Platt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B37","article-title":"Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","author":"Platt","year":"2017, 11","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jvh.12337","article-title":"Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review","volume":"22","author":"Cousien","year":"2015","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B39","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/COH.0000000000000179","article-title":"The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention","volume":"10","author":"Martin","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180626060801_dyx270-B41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13186","article-title":"The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment","volume":"37","author":"Kandeel","year":"2017","journal-title":"Liver Int"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/47\/2\/550\/25087881\/dyx270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:06:13Z","timestamp":1570478773000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article\/47\/2\/550\/4788359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,3]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyx270","relation":{},"ISSN":["0300-5771","1464-3685"],"issn-type":[{"value":"0300-5771","type":"print"},{"value":"1464-3685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,1,3]]}}}